UniProt | Protein Name |
---|---|
P98160 |
|
GO Term | Evidence Code | PMID |
---|---|---|
animal organ regeneration | ||
brain development |
|
|
response to xenobiotic stimulus | ||
angiogenesis | ||
positive regulation of endothelial cell proliferation |
GO Term | Evidence Code | PMID |
---|---|---|
extracellular region | ||
Golgi lumen |
|
|
basement membrane |
|
|
plasma membrane |
|
|
focal adhesion |
GO Term | Evidence Code | PMID |
---|---|---|
collagen V binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:0060277 | pontocerebellar hypoplasia type 8 | |
DOID:0060278 | pontocerebellar hypoplasia type 9 | |
DOID:0060287 | cornea plana | |
DOID:0060318 | acute promyelocytic leukemia | |
DOID:0060467 | humeroradial synostosis | |
DOID:0060469 | Miller-Dieker lissencephaly syndrome | |
DOID:0060578 | Noonan syndrome 1 | |
DOID:0060580 | Noonan syndrome 2 | |
DOID:0060581 | Noonan syndrome 3 | |
DOID:0060582 | Noonan syndrome 4 |
HPO ID | HPO Term |
---|---|
HP:0000126 | Hydronephrosis |
HP:0000135 | Hypogonadism |
HP:0000160 | Narrow mouth |
HP:0000175 | Cleft palate |
HP:0000205 | Pursed lips |
HP:0000211 | Trismus |
HP:0000218 | High palate |
HP:0000232 | Everted lower lip vermilion |
HP:0000238 | Hydrocephalus |
HP:0000248 | Brachycephaly |
Disease ID | Disease Name |
---|---|
ORPHA:1606 |
|
ORPHA:800 |
|
ORPHA:1865 |
|
OMIM:255800 |
|
OMIM:224410 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
175126 | WB:WBGene00006787 | ||
45320 | FB:FBgn0284408 | ||
565429 | ZFIN:ZDB-GENE-080807-4 | DANRE24960 | |
100380784 | SALSA43220 | ||
115165633 | SALTR88020 | ||
103467813 | POERE30093 | ||
102290874 | HAPBU05628 | ||
113013483 | ASTCA20652 | ||
108696836 | Xenbase:XB-GENE-17341349 | ||
100494785 | Xenbase:XB-GENE-6465357 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024